Accelerating thrombolysis using a precision and clot-penetrating drug delivery strategy by nanoparticle-shelled microbubbles
Conventional thrombolytic drugs for vascular blockage such as tissue plasminogen activator
(tPA) are challenged by the low bioavailability, off-target side effects and limited penetration …
(tPA) are challenged by the low bioavailability, off-target side effects and limited penetration …
Accelerating thrombolysis using a precision and clot-penetrating drug delivery strategy by nanoparticle-shelled microbubbles
S Wang, X Guo, W Xiu, Y Liu, L Ren, H Xiao… - Science …, 2020 - dr.ntu.edu.sg
Conventional thrombolytic drugs for vascular blockage such as tissue plasminogen activator
(tPA) are challenged by the low bioavailability, off-target side effects and limited penetration …
(tPA) are challenged by the low bioavailability, off-target side effects and limited penetration …
[PDF][PDF] Accelerating thrombolysis using a precision and clot-penetrating drug delivery strategy by nanoparticle-shelled microbubbles
S Wang, X Guo, W Xiu, Y Liu, L Ren, H Xiao, F Yang… - 2020 - researchgate.net
Conventional thrombolytic drugs for vascular blockage such as tissue plasminogen activator
(tPA) are challenged by the low bioavailability, off-target side effects and limited penetration …
(tPA) are challenged by the low bioavailability, off-target side effects and limited penetration …
[引用][C] Accelerating thrombolysis using a precision and clot-penetrating drug delivery strategy by nanoparticle-shelled microbubbles
S Wang, X Guo, W Xiu, Y Liu, L Ren, H Xiao… - Science …, 2020 - ui.adsabs.harvard.edu
Accelerating thrombolysis using a precision and clot-penetrating drug delivery strategy by
nanoparticle-shelled microbubbles - NASA/ADS Now on home page ads icon ads Enable full …
nanoparticle-shelled microbubbles - NASA/ADS Now on home page ads icon ads Enable full …
[HTML][HTML] Accelerating thrombolysis using a precision and clot-penetrating drug delivery strategy by nanoparticle-shelled microbubbles
S Wang, X Guo, W Xiu, Y Liu, L Ren, H Xiao… - Science …, 2020 - ncbi.nlm.nih.gov
Conventional thrombolytic drugs for vascular blockage such as tissue plasminogen activator
(tPA) are challenged by the low bioavailability, off-target side effects and limited penetration …
(tPA) are challenged by the low bioavailability, off-target side effects and limited penetration …
Accelerating thrombolysis using a precision and clot-penetrating drug delivery strategy by nanoparticle-shelled microbubbles
S Wang, X Guo, W Xiu, Y Liu, L Ren, H Xiao… - Science …, 2020 - scholars.cityu.edu.hk
Conventional thrombolytic drugs for vascular blockage such as tissue plasminogen activator
(tPA) are challenged by the low bioavailability, off-target side effects and limited penetration …
(tPA) are challenged by the low bioavailability, off-target side effects and limited penetration …
Accelerating thrombolysis using a precision and clot-penetrating drug delivery strategy by nanoparticle-shelled microbubbles
S Wang, X Guo, W Xiu, Y Liu, L Ren… - Science …, 2020 - pubmed.ncbi.nlm.nih.gov
Conventional thrombolytic drugs for vascular blockage such as tissue plasminogen activator
(tPA) are challenged by the low bioavailability, off-target side effects and limited penetration …
(tPA) are challenged by the low bioavailability, off-target side effects and limited penetration …
Accelerating thrombolysis using a precision and clot-penetrating drug delivery strategy by nanoparticle-shelled microbubbles.
S Wang, X Guo, W Xiu, Y Liu, L Ren, H Xiao… - Science …, 2020 - europepmc.org
Conventional thrombolytic drugs for vascular blockage such as tissue plasminogen activator
(tPA) are challenged by the low bioavailability, off-target side effects and limited penetration …
(tPA) are challenged by the low bioavailability, off-target side effects and limited penetration …